Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
J Biomol Struct Dyn ; : 1-15, 2023 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-37723871

RESUMEN

Alzheimer's disease (AD) is the leading cause of dementia in older adults. Drug repositioning is a process of finding new therapeutic applications for existing drugs. One of the methods in drug repositioning is to use the side-effect profile of a drug to identify a new therapeutic indication. The drugs with similar side-effects may act on similar biological targets and could affect the same biochemical process. In this study, we explored the Food and Drug Administration-approved drugs using PROMISCUOUS database to find those that have adverse effects profile comparable with the ligands being studied or used to treat AD. Here, we found that the ropinirole, a dopamine receptor agonist, shared a maximum number of side-effects with the drugs proven beneficial for treating AD. Furthermore, molecular modelling demonstrated that ropinirole exhibited strong binding affinity (-9.313 kcal/mol) and best ligand efficiency (0.49) with sigma-1 receptor. Here, we observed that the quaternary amino group of ropinirole is essential for binding with sigma-1 receptor. Molecular dynamic simulation indicated that the movement of the carboxy-terminal helices (α4/α5) could play a major role in the receptor's physiological functions. The neurotoxicity induced by Aß25-35 in SH-SY5Y cells was reduced by ropinirole at concentrations 10, 30, and 50 µM. The effect on spatial learning and memory was examined in mice with Aß25-35 induced memory deficit using the radial arm maze. Ropinirole (10 and 20 mg/kg) significantly improved the short and long-term memories in the radial arm maze test. Our results suggest that ropinirole has the potential to be repositioned for AD treatment.Communicated by Ramaswamy H. Sarma.

2.
Drug Res (Stuttg) ; 73(5): 296-303, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36878466

RESUMEN

Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer-related death in women after lung cancer. The present study aims to identify potential drug candidates using the PROMISCUOUS database for breast cancer based on side effect profile and then proceed with in silico and in vitro studies. PROMISCUOUS database was used to construct a group of drugs that share maximum side effects with letrozole. Based on the existing literature, ropinirole, risperidone, pregabalin, and gabapentin were selected for in silico and in vitro studies. The molecular docking was carried out using AUTODOCK 4.2.6. MCF-7 cell line was used to evaluate the anti-cancer activity of the selected drugs. PROMISCUOUS database revealed that as many as 23 existing drugs shared between 62 and 79 side-effects with letrozole. From docking result, we found that, ropinirole showed a good binding affinity (-7.7 kcal/mol) against aromatase compared to letrozole (-7.1 kcal/mol) which was followed by gabapentin (-6.4 kcal/mol), pregabalin (-5.7 kcal/mol) and risperidone (-5.1 kcal/mol). From the in vitro results, ropinirole and risperidone showed good anti-cancer activity of IC50 with 40.85±11.02 µg/ml and 43.10±9.58 µg/ml cell viability. Based on this study results and existing literature we conclude that risperidone, pregabalin, and gabapentin are not ideal candidates for repurposing in breast cancer but ropinirole could be an excellent choice for repurposing in breast cancer after further studies.


Asunto(s)
Neoplasias de la Mama , Femenino , Humanos , Neoplasias de la Mama/tratamiento farmacológico , Letrozol/uso terapéutico , Simulación del Acoplamiento Molecular , Reposicionamiento de Medicamentos , Gabapentina/farmacología , Gabapentina/uso terapéutico , Pregabalina/uso terapéutico , Risperidona/uso terapéutico
3.
Artículo en Inglés | MEDLINE | ID: mdl-23883190

RESUMEN

A new microwave-assisted derivatisation and LC-MS/MS method has been developed for the analysis of nitrofuran metabolites - 3-amino-5-morpholino-methyl-1,3-oxa-zolidinone (AMOZ), 3-amino-2-oxazolidinone (AOZ), 1-aminohydantoin (AHD) and semicarbazide (SEM) - in farm-raised prawns (Penaeus monodon) from the coastal regions of South India. Analysis was carried out by reverse-phase column (Phenomenex Luna C18) with gradient elution using mobile phase A (0.02% acetic acid in water) and mobile phase B (0.02% acetic acid in acetonitrile), at a flow rate of 200 µl min(-1) and an injection volume of 20 µl. Microwave-assisted derivatisation was achieved in 6 min with good recovery. The results showed that the samples collected from Andhra Pradesh and Karnataka contained residues of nitrofuran metabolites in the range from 5.0 to 40 ng g(-1). This work emphasises the importance of ensuring the safety of seafood and that a new method of derivatisation is applicable for the analysis of nitrofuran metabolites in seafood.


Asunto(s)
Antibacterianos/análisis , Residuos de Medicamentos/análisis , Contaminación de Alimentos/análisis , Nitrofuranos/análisis , Penaeidae/química , Mariscos/análisis , Animales , Antibacterianos/efectos adversos , Antibacterianos/metabolismo , Acuicultura , Residuos de Medicamentos/efectos adversos , Residuos de Medicamentos/metabolismo , India , Microondas , Nitrofuranos/efectos adversos , Nitrofuranos/metabolismo , Penaeidae/metabolismo , Mariscos/efectos adversos , Espectrometría de Masas en Tándem
4.
Artículo en Inglés | MEDLINE | ID: mdl-24779904

RESUMEN

Sulphonamides and chloramphenicol antibiotics were analysed by using liquid chromatography-tandem mass spectrometry (LC-MS/MS) in sea and farmed prawn (Penaeus monodon) samples obtained from the coastal region of southern India during 2011-2012. Average recoveries were 77-99% and precision was between 1% and 8%. The results revealed that in sea prawn samples neither of the two antibiotics was detected, but in farmed samples from coastal Andhra Pradesh some sulphonamides were detected in a concentration range greater than the maximum residual limit as set by Council Directive 2377/90 EC.


Asunto(s)
Antibacterianos/análisis , Residuos de Medicamentos/análisis , Contaminación de Alimentos , Inspección de Alimentos/métodos , Penaeidae/metabolismo , Mariscos/análisis , Animales , Acuicultura , Cloranfenicol/análisis , Cromatografía Líquida de Alta Presión , Unión Europea , Inspección de Alimentos/normas , Adhesión a Directriz , Política de Salud , Promoción de la Salud , Humanos , India , Océano Índico , Límite de Detección , Penaeidae/crecimiento & desarrollo , Reproducibilidad de los Resultados , Mariscos/normas , Sulfonamidas/análisis , Espectrometría de Masas en Tándem
5.
Nat Prod Res ; 24(16): 1560-7, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20835957

RESUMEN

Andrographis paniculata has a long history of use in traditional medicine and andrographolide is one of its potent compounds. In this study, a rapid isolation of andrographolide (colourless, bitter and crystalline diterpene lactone) was carried out by a newly developed microwave-assisted extraction. The extraction intensity, time and amount of solvent were optimised prior to this. The conventional heating method provided a 0.4452% yield of andrographolide and microwave heating at 210 W for 40 min provided a 0.589% yield. Compared to conventional extraction procedures, the results suggested that the proposed method was an effective alternative for the extraction of andrographolide. The isolated compounds were found to be the same by UV, HPTLC and 1H-NMR studies. The isolated andrographolide was tested for in vitro antioxidant activity, and showed a potent free radical scavenging activity.


Asunto(s)
Andrographis/química , Diterpenos/aislamiento & purificación , Microondas , Andrographis/efectos de la radiación , Plantas Medicinales/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA